Tapering bDMARDs in axial SpA - what is the current evidence?
- PMID: 30903025
- DOI: 10.1038/s41584-019-0201-2
Tapering bDMARDs in axial SpA - what is the current evidence?
Comment on
-
Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis.Arthritis Res Ther. 2019 Jan 8;21(1):11. doi: 10.1186/s13075-018-1772-z. Arthritis Res Ther. 2019. PMID: 30621746 Free PMC article. Clinical Trial.
Similar articles
-
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.Arthritis Rheumatol. 2019 Apr;71(4):599-611. doi: 10.1002/art.40753. Epub 2019 Mar 8. Arthritis Rheumatol. 2019. PMID: 30343531 Free PMC article. Clinical Trial.
-
Toxicological considerations in the treatment of axial spondylo-arthritis.Expert Opin Drug Metab Toxicol. 2020 Aug;16(8):663-672. doi: 10.1080/17425255.2020.1783240. Epub 2020 Jun 27. Expert Opin Drug Metab Toxicol. 2020. PMID: 32552128 Review.
-
Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis.Arthritis Care Res (Hoboken). 2017 Jun;69(6):867-874. doi: 10.1002/acr.23090. Arthritis Care Res (Hoboken). 2017. PMID: 27696735
-
2018 APLAR axial spondyloarthritis treatment recommendations.Int J Rheum Dis. 2019 Mar;22(3):340-356. doi: 10.1111/1756-185X.13510. Epub 2019 Feb 28. Int J Rheum Dis. 2019. PMID: 30816645
-
Emerging treatment options for spondyloarthritis.Best Pract Res Clin Rheumatol. 2018 Jun;32(3):472-484. doi: 10.1016/j.berh.2019.01.014. Epub 2019 Feb 21. Best Pract Res Clin Rheumatol. 2018. PMID: 31171316 Review.
Cited by
-
Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view.RMD Open. 2020 Jun;6(2):e001314. doi: 10.1136/rmdopen-2020-001314. RMD Open. 2020. PMID: 32584782 Free PMC article.
References
-
- Sieper, J. & Poddubnyy, D. Axial spondyloarthritis. Lancet 390, 73–84 (2017). - DOI
-
- Smolen, J. S. et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann. Rheum. Dis. 73, 6–16 (2014). - DOI
-
- Gratacós, J. et al. Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis. Arthritis Res. Ther. 21, 11 (2019). - DOI
-
- Van Der Heijde, D. et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann. Rheum. Dis. 76, 978–991 (2017). - DOI
-
- Rudwaleit, M. et al. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann. Rheum. Dis. 68, 777–783 (2009). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources